Dr Reddy’s gets DCGI nod for trial of Covid vaccine Sputnik V in India

After the Indian drug regulator turned down Dr. Reddy’s Laboratories Ltd’s proposal earlier this month to conduct direct Phase-3 human trials for the Russian Covid-19 vaccine Sputnik V, the company and Russia’s sovereign wealth fund Russian Direct Investment Fund (RDIF) have now received the Drug Control General of India (DCGI) nod to conduct an adaptive Phase 2/3 human clinical trial for the Russian vaccine in India.

WashingtonPost_bigger

U.S. citizen kidnapped in West African nation of Niger, officials say

NYT_bigger

Miles Taylor, a Former Homeland Security Official, Reveals He Was ‘Anonymous’

TheTelegraph_bigger

Coronavirus latest news: Pandemic disruption could mean 50,000 people living with undiagnosed cancer

SCMP_bigger

As India records 8 million coronavirus cases, demand for home remedies is booming

WashingtonPost_bigger

U.S. citizen kidnapped in West African nation of Niger, officials say

NYT_bigger

Miles Taylor, a Former Homeland Security Official, Reveals He Was ‘Anonymous’

TheTelegraph_bigger

Coronavirus latest news: Pandemic disruption could mean 50,000 people living with undiagnosed cancer

SCMP_bigger

As India records 8 million coronavirus cases, demand for home remedies is booming

TheGuardian_bigger

US hospital systems facing ‘imminent’ threat of cyber attacks, FBI warns

WashingtonPost_bigger

What the U.S. election means for India

TheGuardian_bigger

Steer escapes Sydney private school and goes on the run on city’s north shore